Ruti Aga and the six-year ban: a fake prescription from a clinic that never existed

The prescription had everything a valid medical document requires: a patient name, a diagnosis, a drug name, a dosage, a signature, a stamp. It lacked exactly one thing — the clinic named on it did not exist. When the Athletics Integrity Unit (AIU) wrote to verify, the clinic replied that it had never issued any such document. The signatory, a “doctor”, turned out to be a family member with no medical registration number. She explained that she had used an old prescription pad left over from a previous workplace; that workplace confirmed she had never been an employee there. Four layers of verification, four collapses of the file. Ruti Aga, the 2026 Tokyo Marathon champion, was banned for six years.

What decided the sanction was not the substance. It was the paper.

Aga is 32, Ethiopian, and belongs to the elite tier of women's marathon running in the 2026–2026 window: Tokyo Marathon winner in 2026, three-time runner-up at World Marathon Majors — the statement does not specify which races, and I record that gap rather than filling it from memory. In March she won a half marathon in China. No finishing time was published, including in the AIU statement, so any inference about the sporting meaning of that win remains an inference. The sample from that race tested positive for methylprednisolone. On 10 September she was provisionally suspended; the eventual sanction was six years, handled by the AIU — World Athletics' independent integrity body — under the WADA Code.

One correction is necessary before going further, because it changes how the whole case reads. Many reports describe methylprednisolone as a “steroid”. More precisely, it is a synthetic glucocorticoid, WADA class S9, prohibited in-competition only, and listed as a Specified Substance — a category recognised as more plausibly linked to therapeutic or inadvertent use. It is not an anabolic-androgenic steroid. That distinction determines the baseline sanction and determines whether a medical explanation is credible at all.

Aga said she was treating a knee injury.

The arithmetic of a sanction

Six years is the sum of two penalties: two years for the presence of a prohibited substance, four years for tampering with evidence during results management. Under the WADA Code, multiple violations are served consecutively, not concurrently. Two plus four equals six in the literal sense of the sum.

The structure of the penalty deserves close reading. For a Specified Substance the baseline is two years, reducible where the athlete proves there was no intent to enhance performance, and extendable to four where intent is established. For tampering with results management the baseline is four years, reducible only in a very narrow set of circumstances. Aga landed in the first box at its lowest end, then in the second box at its full baseline.

What matters is the ratio. The penalty for the cover-up was twice the penalty for the positive test. The drafters of the WADA Code built it that way on purpose: results management is the infrastructure of the entire anti-doping system, and infrastructure has to be protected more heavily than whatever runs on top of it. If an athlete could file forged documents and walk away with a lighter sentence, the verification system would collapse from the inside.

The evidentiary chain here is airtight. The AIU did not stop at the prescription. They verified the clinic's existence, checked the signatory's registration status, and cross-checked the claim about the former employer with that employer. Four independent sources, four denials. For documentary evidence, verification now takes days, not months. Anyone who thought an old prescription pad could cover a positive sample is underestimating how automated the checking process has become.

The road not taken

There is a fork in this case that was never taken, and it matters more than the sanction itself.

Glucocorticoids have a clear legal therapeutic pathway: a Therapeutic Use Exemption. A genuine knee treatment, with a properly obtained TUE and an administration route that fell outside the in-competition window, could have produced no violation at all, or a substantially reduced sanction. The statement does not disclose the route of administration — intra-articular injection or oral, how close to competition. If it was an intra-articular injection near competition day, the in-competition prohibition is triggered automatically absent a TUE.

The soft half of the case was the substance. The hard half was the paper. The fabrication destroyed the very exit the substance left open. An honest therapeutic error, fully disclosed, might have been a lesson and a short ban. A prescription from a phantom clinic is a separate offence with a separate penalty, and no mitigating factor can attach to it.

The arithmetic of age and the arithmetic of money

Aga is 32. For women's marathoners, the competitive peak commonly extends into the mid-to-late thirties. She was inside the most productive window, not past it. A six-year ban from 10 September pushes her return to roughly age 38.

Physically, 38 is still viable for elite marathon running; plenty of women race at world level beyond that mark. Structurally, six years away from elite competition is a gap that barely closes: training structures, support staff, race invitations, and the appearance-fee invitations that travel with them all disappear with the ban. The probability of returning to World Marathon Majors podium level after a six-year layoff is very low. The sanction ends the career in practice, even though on paper it is a fixed-term ban.

The commercial damage arrives before the competitive damage. The Chinese half marathon result is almost certainly annulled, taking the prize money with it. Major invitations vanish for six years. Sponsorship contracts meet their morality clauses — standard practice in doping cases, and the first door sponsors knock on when a name appears in an AIU statement. For a road racer, appearance fees and major invitations are the two core revenue lines; both close at once, and close permanently.

Why one case does not describe a system

Ethiopia and Kenya operate a women's marathon pipeline so deep that one individual leaving the circuit barely registers on the competitive field. Aga was one node in that pipeline — a node with a real record, a Major title and three runner-up finishes at the highest level, but a node nonetheless. The competitive balance of women's marathon does not shift after this ban. What shifts is the reputational premium of the Ethiopian road-running brand, an intangible asset that agents, organisers and sponsors all rely on.

The venue matters too: a half marathon in China. For years the Chinese road circuit has been where East African athletes converge to race for appearance fees — high race volume, thinner testing density, and pressure to appear at multiple events in a single season. Based on my experience following distance races, this is an environment that breeds rushed medical decisions: a sore knee before a flight, an injection to protect an appearance, and someone in the camp improvising the paperwork.

The failure of an entire circle

Read closely, the construction of the forged file reveals amateurism. A relative signs. An old prescription pad. A clinic that does not exist. A sophisticated doping operation would not look like this. This is an improvised cover-up executed by people with no expertise in sports integrity. The amateurism is itself the symptom: the circle around a world-class athlete was missing a basic function — compliance counsel.

An athlete with a lawyer who understood the process would never have taken this route. They would have declared, applied for a retroactive TUE where eligible, or admitted a therapeutic error and accepted a far lighter sanction. Responsibility here extends beyond Aga; it reaches whoever advised or actively helped assemble the file, and it reaches a system that never equipped her with someone who knew what they were doing.

I once thought I came to commentate matches, and discovered I came to listen to people. In this job I learned one thing: an athlete's name is the first door of respect. I once mispronounced a player's name three times in a single half and spent the following month correcting every syllable. So when I write about Aga, I am not writing about a line in a sanction table. I am writing about a 32-year-old woman who has run 42.195 kilometres faster than almost anyone on the planet, and who now stands on the far side of her career.

The contrarian angle: the system rewards honesty, deliberately

The obvious reaction is that six years is heavy for a substance in the therapeutic class. Reading it backwards reveals the logic: had Aga told the truth from the start, her baseline was two years, and with a genuine therapeutic context and cooperation that figure could have fallen further. She tripled her own sanction with a single sheet of paper.

This is the most counterintuitive feature of the entire anti-doping system: the instinct to protect the athlete — a deeply human, entirely understandable instinct, usually enabled by an entourage — is the most expensive instinct available. The system does not punish error more heavily than concealment. It punishes concealment more heavily than error, deliberately and publicly, so that forging documents never again looks like a cheap exit.

The framing also needs care. Calling methylprednisolone a “steroid” leads the public to picture a doping programme, when the reality is closer to a knee treatment handled with the wrong procedure. The severity of this story comes from paperwork, not pharmacology. That does not make it lighter, because paperwork is precisely what protects clean athletes from people willing to manufacture evidence.

Another temptation should be resisted: extrapolating to “systemic Ethiopian doping”. The evidence does not support it. A single, clumsy case handled by a family improvising on its own is not a sign of an organised scheme. Read correctly, the clumsiness points the other way.

What remains after the ban

Records are only an excuse to remember a person, not a number. Aga will be remembered not for Tokyo 2026, but for an old prescription pad.

Every time I pick up a microphone, I learn to be quieter inside my own head. And the question I keep from this case is not directed at Aga. It is directed at the moment the positive-test letter was placed in the hands of a 32-year-old athlete in an Ethiopian highland town: who was sitting beside her then? Federations pay for training camps, shoes, flights. Does anyone pay for a phone call to a lawyer?

If the answer is still no, the next forged prescription is only a matter of time.